Analysts Viewpoint Leerink Partners downgrades AN2 Therapeutics Inc (ANTX) stock to a Market perform AN2 Therapeutics Inc’s recent filing unveils that its 10% Owner Leonard Braden Michael unloaded Company’s shares for reported $0.22 million